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The Bis(Indolyl)Imidazole Alkaloid Nortopsentin A Exhibits
Antiplasmodial Activity
Stephenie Alvarado,a Bracken F. Roberts,a Amy E. Wright,b Debopam Chakrabartia
Burnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida, USAa; Harbor Branch Oceanographic Institute at Florida Atlantic University, Fort
Pierce, Florida, USAb

O

ver 300 million clinical cases of malaria occur annually, resulting in more than 1 million deaths (1). Unfortunately,
because of the prevalence of drug-resistant malaria parasite
strains, existing drugs are increasingly losing their efficacy. Therefore, there is an urgent need to identify new drug leads to reduce
the global malaria burden. Marine biological diversity provides an
excellent opportunity to identify novel drug leads from secondary
metabolites of marine organisms. Although research aiming to
discover novel marine-derived antiplasmodial agents is relatively
recent, over 60 active compounds have been reported to date (2).
One of the more important leads is manzamine A, a structurally
complex ␤-carboline alkaloid isolated from a Haliclona sp. Manzamine A cleared 90% of the parasite burden in P. berghei-infected
mice with a single intraperitoneal dose (3, 4). Unfortunately, toxicity issues have limited the clinical development of the compound.
A library of enriched chemical fractions derived from marine
organisms collected at depths greater than 50 m was prepared at

Harbor Branch Oceanographic Institute using medium-pressure
liquid chromatography on an ISCO Combiflash purification system. These materials were screened for their ability to inhibit the
chloroquine-sensitive P. falciparum strain 3D7 and the chloroquine-resistant strain Dd2. The enriched fractions were solubilized in ethanol and, when necessary, further diluted in culture
medium for assay. The inhibitory properties of the library were
evaluated at 5 g/ml using a SYBR green I assay (5, 6) with the
chloroquine-sensitive P. falciparum strain 3D7 (1% parasitemia)
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FIG 1 In vitro antiplasmodial and cytotoxic analysis of nortopsentin A. (A) Antiplasmodial activity of nortopsentin A in chloroquine-sensitive (3D7) and
chloroquine-resistant (Dd2) strains of P. falciparum. Asynchronous cultures were exposed to different concentrations of inhibitor for 72 h. (B) Cytotoxicity of
nortopsentin A. Various concentrations of nortopsentin A were incubated with NIH 3T3 fibroblasts for 48 h to determine cytostatic activity. Data points are
averages of at least 3 independent experiments, each done in triplicate. Error bars represent standard deviations.
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A library of enriched marine natural product fractions was screened for their antiplasmodial activity using a SYBR green I
fluorescence-based assay. Fractions derived from a sponge of the genus Spongosorites exhibited potent inhibition of Plasmodium
falciparum growth. This genus of sponge has been reported to contain the nortopsentin and topsentin class of bis-indole imidazole alkaloids. This is the first report of nortopsentin A inhibiting parasite growth at the trophozoite stage at submicromolar
50% inhibitory concentrations (IC50).

Antiplasmodial Bis(Indolyl)Imidazoles

TABLE 1 Structure-activity relationship of bis(indolyl)imidazole alkaloidsa
IC50 (M) for:
NIH 3T3
cells

Selectivity index

Nortopsentin A

0.46

6.6

14.3

Hamacanthin A

3.1

18.9

6.1

Dragmacidin D

4.3

17.9

4.2

Dragmacidin

6.8

4.5

0.7

Bis(2,2)-6-bromo-indol-3-yl-ethyl amine

8.7

15.9

1.8

Deoxytopsentin

10.3

12.7

1.2

Hamacanthin B

⬎20

19.1

⬍0.9

a

Structure

Data shown are the result of at least 3 independent experiments, each done in triplicate.

grown in 100 l RPMI 1640 medium supplemented with 25 mM
HEPES, 11 mM glucose, 25 mM NaHCO3, 100 M hypoxanthine,
0.5% Albumax I, 25 g/ml gentamicin, and human A⫹ red blood
cells (RBC) (2% hematocrit) at 37°C in an atmosphere of 5% CO2
and 95% air for 72 h. Among the fractions that exhibited ⬎95%
inhibition at 5 g/ml were those from a Spongosorites sp. (organism number 5-IV-05-1-002, collected off Lucaya, Bahamas, at a
depth of 168 m). Earlier liquid chromatography-mass spectrometry (LC-MS) analysis indicated that nortopsentin A was present
as the major component of the active fraction from this organism
(7). Nortopsentin A is a bis(indolyl)imidazole alkaloid with antiinflammatory and antitumor properties that has been previously
identified from related specimens of Spongosorites (8, 9) and has
never been tested for antiplasmodial activity.
To determine if nortopsentin A showed antiplasmodial activity, 50% inhibitory concentrations (IC50s) in both chloroquinesensitive (3D7) and chloroquine-resistant (Dd2) P. falciparum
strains were screened with serial dilutions of compound. The
IC50s in 3D7 and Dd2 were 460 nM and 580 nM, respectively,
using SYBR green I assays with Z factors of ⬎0.9. Although a
nortopsentin A structure having aromatic systems in conjugation
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may emit autofluorescence, our tests show that it did not exhibit
any autofluorescence at the concentrations used in this study. To
determine the selectivity of this class of inhibitor against malaria,
cytotoxicity against NIH 3T3 fibroblasts was evaluated using an
MTS [(3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium)] assay (CellTiter 96
aqueous nonradioactive cell proliferation assay; Promega). The
test revealed that nortopsentin A has a selectivity index greater
than 14, with an IC50 in fibroblasts of 6.6 M (Fig. 1; Table 1).
To gain some insight into structure-activity relationships, a
collection of six additional bis(indolyl) natural products that vary
in the linking unit between the indole rings was screened using the
above-mentioned SYBR green I and MTS assays. The antiplasmodial activities, cytotoxicities, and selectivity indices with respect to
these structures are shown in Table 1. Nortopsentin A was the
most potent and had the greatest selectivity of all the compounds
tested. Deoxytopsentin, which has a keto group adjacent to the
imidazole linker, was approximately 10-fold less potent, with a
reduced selectivity of 1.2. A series of analogs which contain a sixmembered-ring nitrogen heterocycle as the linker unit but which
vary in the degree of unsaturation of the linking heterocycle [rang-
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P. falciparum Dd2

Compound
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FIG 2 Effect of nortopsentin A on intraerythrocytic development. The development of synchronized P. falciparum 3D7 in the presence of 3 M nortopsentin
A was assessed. Giemsa-stained thin blood smears were examined at 0, 16, 32, and 48 h to determine developmental stages. As expected, the control progressed
from ring to trophozoite to schizont and to rings and segmenters throughout the 48-h time course. The nortopsentin A-treated culture shows halted progression
at the trophozoite stage.
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ture-activity studies are needed to improve the potency and selectivity of this class of compound for it to be seriously considered a
candidate for lead optimization.
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ing from 2-(1H)-pyrazinones to 5,6-dihydro-2-(1H)-pyrazinones
to a fully saturated piperazine] were tested. In this series, the activity against the malaria parasite was all in the low-micromolar
range, but the selectivity was lost with increasing saturation and
may correlate to loss of planarity of the molecules. Hamacanthin
A was an exception to this, as it retained some selectivity for the
parasite. In hamacanthin B, where the linkage to the 5,6-dihydro2-(1H)-pyrazinone changes to the 5 position, the activity against
the malaria parasite is lost (⬎20 M), while cytotoxicity to the
NIH 3T3 cell line is retained. The overall trend observed in the
series of compounds tested is consistent with the hypothesis that
optimal activity and selectivity may correlate to planarity of the
molecule and distance between the two indole rings. Additional
modeling and testing of new analogs would be required to confirm
this hypothesis.
To better understand the mechanism of action of nortopsentin
A against the malaria parasite, a sorbitol-synchronized Plasmodium falciparum 3D7 culture was split into two groups, one
treated with a 3 M concentration of the compound and one
maintained without compound. Samples were collected at 16-h
intervals for 48 h for Giemsa staining of thin smears. As can be
seen in Fig. 2, the control culture matured from the ring stage (0 h)
through the early trophozoite stage (16 h) to the mature-trophozoite/early-schizont stage (32 h) and finally to the segmenter/ring
stage (48 h). However, the development of the nortopsentin Atreated culture was blocked at the early trophozoite stage. Previous studies of this alkaloid have shown that topsentins can act as
DNA-intercalating agents and halt DNA synthesis (10). Our results correlate well with this suggested mechanism of nortopsentin
A. The DNA synthesis in Plasmodium begins at the trophozoite
stage of asexual, erythrocytic growth (11, 12). If nortopsentin A
binds to DNA during the ring stage of development, DNA synthesis in the trophozoite stage will likely be inhibited, and progression
of the cell cycle would cease. Further studies are needed to fully
understand the mechanism by which nortopsentin A inhibits the
growth of P. falciparum.
The fact that only a limited number of clinically relevant drugs
are available for malaria therapy is of serious concern. To overcome drug resistance issues, it is important to identify chemical
entities with structural features distinct from known antimalarials. This study has identified a novel chemical scaffold from a
marine macroorganism as an antiplasmodial agent. Further struc-

